ISA features in TV program De Barometer on RTL-Z 16 Feb 2021 Previous First Patient Treated in Phase II Combination Trial of ISA Pharmaceuticals’ Lead Immunotherapy ISA101b with Keytruda® Next ISA Pharmaceuticals selects product candidate for clinical trial with first in class COVID-19 immunotherapy